Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion type Assertion NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_head.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion description "[We investigated the mRNA levels of hepcidin (HAMP), HFE, neogenin (NEO1), transferrin receptor 1 (TFRC), transferrin receptor 2 (TFR2), and hemojuvelin (HFE2) in normal human brain, brain tumors, and astrocytoma cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_provenance.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion evidence source_evidence_literature NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_provenance.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion SIO_000772 19386095 NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_provenance.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion wasDerivedFrom befree-2016 NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_provenance.
- NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_assertion wasGeneratedBy ECO_0000203 NP734081.RAViGL2URO-7KkpUicwumD5LyzUYpF3vB6a0S1rGNXANg130_provenance.